F. Brito

A hypothesis for the mode of action of anti‐rheumatic drugs in a model of cartilage destruction

D. Willoughby, A. Moore, A. Sedgwick, 1985, The Journal of pharmacy and pharmacology.

Type 4 phosphodiesterase inhibitors and their potential in the treatment of inflammatory disease

F. Brito, J. Souness, P. Warne, 1997 .

Aspectos Farmacogenéticos Associados à Resistência Terapêutica Antiplaquetária em Pacientes com Síndrome Coronariana Aguda Pharmacogenetic Aspects Associated with Anti-Platelet Therapy Resistance in Patients with Acute Coronary Syndrome

E. Mesquita, E. Medina-Acosta, F. Pena, 2010 .

Inflamação e Aterosclerose: Novos Biomarcadores e Perspectivas Terapêuticas Inflammation and Atherosclerosis: New Biomarkers and Outlooks for Treatment

M. M. Fumian, F. Brito, J. Castro, 2013 .

Drug effects on a novel model of connective tissue breakdown

M. J. Holmes, D. Willoughby, S. Carney, 1987, Agents and Actions.